Incannex Healthcare Limited (IHL.AX)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2024-12-31 2024-06-30 2024-03-31 2023-12-31
Revenue 12,000 12,000 0 0
Cost of Revenue 0 0 0 0
Gross Profit 12,000 12,000 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,602,000 5,294,000 4,138,000 5,345,000
Operating Expenses 5,016,000 9,756,000 7,415,000 7,983,000
Operating Income -5,004,000 -9,744,000 -7,415,000 -7,983,000
Interest Expense 171,000 0 0 0
Income Before Tax -5,894,000 -6,431,000 -6,031,000 -5,241,000
Income Tax Expense 0 30,000 0 0
Net Income -5,894,000 -6,461,000 -6,031,000 -5,241,000
Per Share
EPS -0.33 -0.38 -0.38 -0.33
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Revenue 86,000 12,000 0 0 0
Cost of Revenue 0 0 88,080 0 6,338
Gross Profit 86,000 12,000 0 0 -6,338
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 13,128,000 17,071,000 7,924,000 0 10,179,778
Operating Expenses 23,875,000 30,053,000 13,638,000 0 14,769,216
Operating Income -23,789,000 -30,041,000 -49,668,000 0 -21,478,927
Interest Expense 303,000 0 3,013 0 9,116
Income Before Tax -46,885,000 -18,429,000 -48,811,000 0 -14,903,909
Income Tax Expense 0 30,000 0 0 -6,584,134
Net Income -46,885,000 -18,459,000 -48,811,000 0 -8,319,775
Per Share
EPS -1.36 -1.14 -3.17 0.00 -0.01
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 15,039,000 5,858,000 33,363,228 37,500,931
Short Term Investments 0 0 0 0
Net Receivables 4,626,000 10,015,000 287,478 318,841
Inventory 0 0 0 -27,146
Total Current Assets 19,962,000 16,202,000 34,685,887 37,879,608
Property Plant Equipment 485,000 845,000 1,187,386 0
Goodwill and Intangibles 0 0 52,717,427 0
Total Assets 20,447,000 17,047,000 88,590,700 37,879,608
Liabilities
Account Payables 6,074,000 527,000 3,675,090 1,300,696
Short Term Debt 184,000 163,000 170,656 0
Total Current Liabilities 6,984,000 5,620,000 3,845,746 2,010,533
Long Term Debt 74,000 210,000 616,087 0
Total Liabilities 7,058,000 5,830,000 4,461,833 2,010,533
Shareholders Equity
Retained Earnings -157,556,000 -110,671,000 -78,774,468 -58,794,910
Total Shareholders Equity 13,389,000 11,217,000 84,128,867 35,869,075
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 15,039,000 5,858,000 33,363,228 37,500,931 9,123,617
Short Term Investments 0 0 0 0 0
Net Receivables 4,626,000 10,015,000 287,478 318,841 169,088
Inventory 0 0 0 -27,146 0
Total Current Assets 19,962,000 16,202,000 34,685,887 37,879,608 9,328,795
Property Plant Equipment 485,000 845,000 1,187,386 0 0
Goodwill and Intangibles 0 0 52,717,427 0 0
Total Assets 20,447,000 17,047,000 88,590,700 37,879,608 9,328,795
Liabilities
Account Payables 6,074,000 527,000 3,675,090 1,300,696 233,117
Short Term Debt 184,000 163,000 170,656 0 0
Total Current Liabilities 6,984,000 5,620,000 3,845,746 2,010,533 755,049
Long Term Debt 74,000 210,000 616,087 0 0
Total Liabilities 7,058,000 5,830,000 4,461,833 2,010,533 755,049
Shareholders Equity
Retained Earnings -157,556,000 -110,671,000 -78,774,468 -58,794,910 -40,681,793
Total Shareholders Equity 13,389,000 11,217,000 84,128,867 35,869,075 8,573,746
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -46,885,000 -18,459,000 -19,979,558 -14,903,909
Depreciation & Amortization 246,000 103,000 130,946 0
Stock Based Compensation 2,609,000 8,928,000 3,191,640 1,464,550
Change in Working Capital 6,775,000 -9,468,000 720,575 1,226,380
Operating Cash Flow -12,513,000 -15,845,000 -15,942,825 -12,807,373
Investing Activities
Capital Expenditure -8,000 -277,000 -476,873 0
Investments -8,000 -277,000 -476,873 0
Investing Cash Flow -8,000 -277,000 -476,873 -8,999
Financing Activities
Debt Repayment -1,306,000 0 -54,717 0
Common Stock Issued/Repurchased 47,471,000 0 12,330,284 41,184,687
Dividends Paid 0 0 0 0
Financing Cash Flow 21,396,000 0 12,275,567 41,184,687
Summary
Free Cash Flow -12,521,000 -16,122,000 -16,419,698 -12,807,373
Net Change in Cash 9,181,000 -16,262,000 -4,137,703 28,377,315
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -46,885,000 -18,459,000 -19,979,558 -14,903,909 -8,163,590
Depreciation & Amortization 246,000 103,000 130,946 0 0
Stock Based Compensation 2,609,000 8,928,000 3,191,640 1,464,550 0
Change in Working Capital 6,775,000 -9,468,000 720,575 1,226,380 0
Operating Cash Flow -12,513,000 -15,845,000 -15,942,825 -12,807,373 0
Investing Activities
Capital Expenditure -8,000 -277,000 -476,873 0 0
Investments -8,000 -277,000 -476,873 0 0
Investing Cash Flow -8,000 -277,000 -476,873 -8,999 29,277
Financing Activities
Debt Repayment -1,306,000 0 -54,717 0 0
Common Stock Issued/Repurchased 47,471,000 0 12,330,284 41,184,687 12,401,230
Dividends Paid 0 0 0 0 0
Financing Cash Flow 21,396,000 0 12,275,567 41,184,687 12,401,230
Summary
Free Cash Flow -12,521,000 -16,122,000 -16,419,698 -12,807,373 -6,910,280
Net Change in Cash 9,181,000 -16,262,000 -4,137,703 28,377,315 5,520,227